Applied DNA Sciences Files 8-K on Shareholder Votes

Ticker: BNBX · Form: 8-K · Filed: Feb 28, 2025 · CIK: 744452

Sentiment: neutral

Topics: shareholder-vote, corporate-governance

Related Tickers: APDN

TL;DR

APDN filed an 8-K for shareholder votes on Feb 28, 2025. Details TBD.

AI Summary

Applied DNA Sciences, Inc. filed an 8-K on February 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions presented, but it serves as an official notification of such events.

Why It Matters

This filing indicates that Applied DNA Sciences held a shareholder meeting or took action requiring a vote, which could impact corporate governance and future strategic decisions.

Risk Assessment

Risk Level: low — The filing is a procedural notification of shareholder votes and does not contain immediate financial or operational risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on February 28, 2025.

What is the principal executive office address for Applied DNA Sciences, Inc.?

The principal executive office address is 50 Health Sciences Drive, Stony Brook, New York 11790.

In which state was Applied DNA Sciences, Inc. incorporated?

Applied DNA Sciences, Inc. was incorporated in Delaware.

What is the Commission File Number for Applied DNA Sciences, Inc.?

The Commission File Number for Applied DNA Sciences, Inc. is 001-36745.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 28, 2025 regarding APPLIED DNA SCIENCES INC (BNBX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing